Loading clinical trials...
Loading clinical trials...
Thrombosis formation is the core mechanism for the occurrence of major adverse cardiovascular and cerebrovascular events in patients with coronary heart disease. Antithrombotic therapy is one of the m...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Beijing Hospital
NCT06916520 · Coronary Arterial Disease (CAD), Percutaneous Coronary Intervention (PCI)
NCT07444957 · Coronary Arterial Disease (CAD), NSTEMI - Non-ST Segment Elevation Myocardial Infarction (MI), and more
NCT07444931 · Coronary Arterial Disease (CAD), Sudden Cardiac Arrest, and more
NCT07025148 · Coronary Arterial Disease (CAD), Percutaneous Coronary Intervention (PCI)
NCT06681740 · Myocardial Ischemia, Coronary Arterial Disease (CAD)
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions